Osseointegration is the activation of quick new bone production, which firmly anchors grafts placed inside the bone (Oh et al., 2023; Pinotti et al., 2023). The implant’s material qualities and mechanical features of the adjacent bone tissue must be compatible. To accomplish effective osseointegration, they must form direct physical and chemical connections with nearby bone surfaces. There should be no formation of fibrous tissue interfaces. For their excellent mechanical characteristics, cobalt chrome alloys and stainless steel are utilized, but the rigidity of solid materials has led to stress protection and destruction of bones. Osseointegration reduces tension as well as strain at the tissue-implant junction for improved implant efficiency and durability (Dondani et al., 2023; Lang et al., 2023; Sigilião Celles et al., 2023).

One of the key problems connected with the rising popularity of uncemented complete joint arthroplasties is osteointegration failures (Zhang C. et al., 2023; Verma et al., 2023). Although prosthetic joints are presently cured to improve osseous ingrowth through surface irregularity, the nanoscale, where cellular relationships take place, stays smooth (Figure 2). This stimulates fibrous because of bone ingrowth, leading to early failure (Katz et al., 2013).

Periprosthetic joint infection is one of the primary causes of primary joint replacement failure and modification (Alrayes M. M. and Sukeik M., 2023; Alrayes M. M. and Sukeik M. T., 2023; Patel, 2023). It has been revealed that adherence to bacteria and colonization are reduced. As a result, controlled antibiotic-releasing prosthetic nanophasic joints may offer a viable solution to the catastrophic risk presented by periprosthetic joint infections (Gusić et al., 2014).

Surface nanostructuring with material can be designed to develop active anti-infective surfaces even at an extremely low level of bacterial adhesion. One of the main advantages is greater efficacy, combating a greater variety of bacteria when antibacterial nanoparticles are applied to the surface of titanium. The latter could help reduce the risk of infections in medical implants. Particles could be designed with a targeting ability to destroy bacteria and, at the same time, minimize the risk of developing resistance to bacteria (Cazzola et al., 2023; Gamna et al., 2024). However, there are disadvantages to consider as well. In the long run, the impact on human tissues may turn out to be potentially toxic. Further, nanoparticles may always exist for an extended possibility of time to leach out, hence giving a potentially reduced antibacterial effect, at the same time possibly being harmful to the environment. Integration of nanoparticles into the titanium surface may result in changes in properties such as strength and durability. One must observe such changes in the performance of medical implants. Further studies and developments will need to be done to optimize such surfaces for safety and effectiveness (Cazzola et al., 2023; Gamna et al., 2024).

Even though primary joint replacement surgery has a high rate of success, its durability is limited. Thin (nano) film coatings may significantly enhance the durability and functionality of artificial joints by providing a robust barrier that minimizes wear and tear through improved friction resistance (Noori et al., 2023). Nanotechnology is used in arthroplasty to target the advancement of materials for implants that are safe to use and efficient while extending the average lifecycle of grafts and averting infection. More favorable contact between the graft and the surrounding bone can be formed by adjusting particular surface features of the graft (Figure 3) (Smith et al., 2018).

The treatment of trauma-induced abnormalities of the segmental bones, fixations on failure, and arthroplasty provides a significant challenge (Boretto et al., 2023; Garabano and Pesciallo, 2023). Current strategies for resolving these problems employing auto/allografts and porous metals have limits of their own, for instance, partial availability, infection risk, and insufficient scaffolding elements, which limit the quantity of osteointegration. Since the degree of biomaterial adherence to host tissues determines the optimal scaffold for promoting osteointegration, nanostructured biomaterials are suitable because osteoblasts may colonize them (Andreacchio et al., 2018). Cells may interact, proliferate, and change into natural tissues on the ultimate scaffolds.

Nanostructured biomaterials can provide structural assistance and suitable pore size while also serving as a medium for the movement and activity of cells. When treated with growth factors and chemokines, they can also give biochemical cues to govern tissue change with pharmacological support by transporting peptide patterns that attach to receptors and stimulate intracellular signaling pathways. Nanomaterials with these characteristics are thought to be ideal for treating massive bone deformities (Luthringer et al., 2013; Roddy et al., 2018). Nanoscaffolds can be used to facilitate more natural healing without the complications linked to implants and biomaterials that do not disintegrate since they will eventually resorb after completing their biochemical, structural, biological, and templating roles (Roddy et al., 2018).

Numerous natural and artificial nanostructured compounds have been investigated for the management of bone deformities (Wan et al., 2023; Wen et al., 2023). Natural biomaterials have the benefit of being highly biocompatible, however, the way they handle features and support from structures is inadequate. Artificial components, in contrast, give outstanding structural support but are not biocompatible. Presently, artificial biomaterials, for example, hydroxyapatite (HA) and derivatives), bioactive ceramics TCP (tricalcium phosphate) and polymers such as poly-lactic acid (PLA) and poly-glycolic acid (PGA), and a mixture of these, referred to as composite matrices is chosen as scaffolding materials used to cure bone deformities because of their enhanced structural support. Surface cure with growth agents of these nanostructured biomaterials, for instance, bone morphogenic proteins (BMP) and bone sialoproteins (BSP) may enhance their capacity to osseointegrate effectively. Natural polymers which include gelatin and fibrin have also been used to repair non-load-bearing bone deformities such as cranial abnormalities (Vasita and Katti, 2006; Bakhori et al., 2023; Krishani et al., 2023). The challenge lies in devising a sterilization protocol for Biomaterial-Based Drug Delivery Systems (BDDS) that incorporate multiple types of base biomaterials, such as combinations involving metals with drugs, metals with molecules, metals with polymers, and polymers with molecules, among other permutations (Figure 4).

However, this revolution in the use of BMP2 to improve bone regeneration does come along with several potential risks, among them being that of inducing abnormal growth of bones (Halloran et al., 2020). This can result in clinical complications, one of which is the undesired formation of bone at the sites nearer to the area of treatment. To have that happen, it would have to be discarded from the area where bone growth is not intended (James et al., 2016). Besides BMP2, a larger class of nanomaterials used for medical interventions carries a number; for example, certain cytotoxic effects of the nanomaterials are likely to bring an adverse response to cells. The high development and implementation cost of nanotechnology remains one of the principal barriers to wide-scale in any sphere of its utilization. Unpredictable results of nanomaterials partially engendered by their complex interplay with biological systems require a more precautionary attitude (Zara et al., 2011). This further underscores the real possibility that current This only indicates further the urgency of very thorough research and regulation that, in some way, would limit the mentioned risks and secure these technologically advanced medical treatments in the best possible way.

Cartilage has a more convoluted structure, making the cure of cartilaginous disorders more complex employing biocompatible or artificial scaffolds. Due to their enhanced capacity for biodegradation, cell infiltration, biocompatibility, and neovascularization (Vasita and Katti, 2006), biological protein scaffolds, for example, collagen and polysaccharide scaffolds for instance hyaluronic acid, chondroitin sulfate, chitosan, and agarose are recommended therapies for cartilage abnormalities. Regardless of their immunoreactivity, type I collagen frameworks are the most frequent. In individuals with chondral defects, acid-treated collagen polymers comprising mesenchymal stem cells (MSC) have been suggested to create hyaline-like cartilage. The denatured form of gelatin is an alternative to collagen that is immune-reactive and ailment-transmissible (Banimohamad-Shotorbani et al., 2023; Jeyaraman et al., 2023).

Since most cartilage abnormalities are manageable and less invasive operational measures, the availability of injectable frameworks is serious. Hydrogels are injectable nanoscale polymeric networks made up of gelatin or collagen, with the capability to consolidate and take on the required form of the issue after embedding. When hydrogels are injected with chondrocytes, they form cartilage-like ECM with increasing mechanical improvement as a result of the ongoing formation of a glycosaminoglycan-rich matrix (Ahmadian et al., 2023; Guo et al., 2023; Stone et al., 2023).

Applying nanofibers to make osteogenic or chondrogenic scaffolds has shown several advantages, including increased propagation, cell adherence, and movement. Nanofiber scaffolds had the largest concentration of type II collagen, an enhanced capability to absorb human blood proteins, as well as a substantial increase in the expression of cartilage-specific genes and proteins, i.e., collagen II and IX. Several reported studies have shown that TE for the management of cartilage and osseous deformities is one of nanotechnology’s most important applications and related studies in orthopaedics (D'Antimo et al., 2017).

Injectable bone matrix composed entirely of nanoparticle-sized hydroxyapatite. After a few months, this is fully assimilated (Appleford et al., 2009). Engineered artificial bone items with bone void filler consisting of HA nanocrystals that have a structure similar to natural bone crystals.

Tricalcium phosphate nanoparticles have been devised as a substitute substance for bone with cancellations prostheses. When contrasting with conventional tricalcium phosphate, their porosity, surface area, vascular invasion, and bioresorption are all increased (Szpalski and Gunzburg, 2002).

Nanocomposite scaffold grafts consisting of nanostructured HA and Type I collagen are employed to repair osteochondral abnormalities in the knee joint.

Osteoporosis is defined by a decrease in bone mass and micro-structural bone injury. It could be either primary or secondary (Adami et al., 2022; Głuszko et al., 2023; Qaseem et al., 2023). Due to osteoporosis, spinal fractures are more prevalent than other types of bone fractures. The goals of osteoporotic vertebral fracture (OVF) treatment are pain relief, restoration of height, as well as the functional integrity of the affected vertebral body. The nanosized bioavailability of calcium citrate and calcium carbonate is improved via nanotechnology, lowers the risk of osteoporosis, and is employed to treat osteoporotic vertebral fractures. Bone fillings, nanomaterials that can be injected, and Polymethyl-methacrylate (PMMA) bone cement can be utilized to perform vertebroplasty and kyphoplasty. With the improvement of calcium sulfate cement (CSC), and calcium phosphate cement (CPC) (Barinov and Komlev, 2011; Świeczko-Żurek et al., 2022), the clinical applications of bone cement have improved. Hydrogels that can be injected are innovative instruments for bone regeneration and healing (Cheng et al., 2023; Li et al., 2023).

A perfect example of injectable NPs for kyphoplasty and vertebroplasty must have good injectability and uniformity during injection. It must have setting characteristics with adequate handling periods. It must have sufficient mechanical strength and rigidity to correspond with neighboring vertebral bodies (Arora et al., 2013). They must provide porous structures for osseointegration and angiogenesis, as well as optimal stimuli for new bone formation. It should be free of necrosis and infection, as well as radiopacity for surgical imaging. Conventional components have monomer toxicity, increased temperatures that cause tissue injury, an inability to incorporate into bone, and severe stiffness that leads to fracture. New bone cement incorporating nanomaterials eliminates these problems. The osteoblast adhesion densities of PMMA bone cement incorporating nano-phase BaSO₄ and MgO are greater than those of PMMA cement alone (Ricker et al., 2008; Karpiński et al., 2019).

The use of CPCs in bone deformities and TE. It is chemically and biologically comparable to normal bone, can be shaped after combining, and is a substitute for PMMA bone cement. CPCs are categorized as either brushite (dihydrate of dicalcium phosphate) or apatite. CPC ultrafine nanofibers, akin to cortical bone, improve fracture resistance. Pores and interconnecting channels for bone ingrowth are created by fiber degradation (Canal and Ginebra, 2011) When PMMA is blended with a 2% aqueous gel solution of sodium hyaluronate, its elastic modulus and yield strength decrease (Liang et al., 2024). The addition of CNTs to CPC increases its strength, as does the bio-mineralization of CNTs (Wang et al., 2007). The combination of bovine serum albumin (BSA) and multiwalled CNTs results in a CPC with superior strength (Chew et al., 2011). The CPC/multi-walled CNT/BSA composite enhances the material’s strength and interface bonding with CPC, as well as its wettability and reactivity. Further, BSA and MWCNT enhance the mechanical characteristics of CPC composites, resulting in stronger materials, and encouraging HA development. Current CPC uses include three-dimensional printing, stem cells, injectability, drug delivery, and growth factor. Their uses comprise prefabricated CPC scaffolds, injectable CPC scaffolds, 3-dimensional printing, and CPC scaffold assembly for bone TE.

Similar to collagen, functionalized SWCNTs serve as frameworks for bone treatment (Zhao et al., 2011). Functionalized SWCNTs are optimal for creating synthetic bone and promoting bone development. They act as a scaffold made for the nucleation of collagen and production of HA in bone when inserted as solutions or scaffolding as a substratum (Zhao et al., 2005) When human mesenchymal stem cells (hMSC) are incubated on TiO₂, tiny nanotubes readily acquire local proteins and generate an ECM-like environment that facilitates hMSC adhesion. Larger nanotubes elongate human mesenchymal stem cells and cause them to differentiate into osteoblastic cell lines (Oh et al., 2009). Greater nanotubes acquire fewer local proteins, and human mesenchymal stem cells (hMSCs) create filopodia to cover a broader surface area and ensure optimal adherence. This method enhances osteoinduction involving gene treatment (Figure 6) (Bhakta et al., 2005; Polini et al., 2011).

Nanostructures designed for orthopedic treatments often exhibit unique surface morphologies, such as high porosity or specific topographies that encourage bone cell adherence and proliferation, thereby aiding in bone tissue integration (Liang et al., 2024). The internal structure, potentially visible through high-resolution imaging, might include a strategic arrangement of pores or channels that supports nutrient flow and waste removal, mimicking natural bone architecture. These features collectively work to enhance the mechanical properties of implants, ensure biocompatibility, and improve patient outcomes by accelerating the healing process and reducing the likelihood of implant rejection (Chen et al., 2023).

Loss of tissues or organs is caused by old age, illness, injury, and certain genetic defects. The method of repairing fractionally depleted tissues is known as regenerative medicine. Regenerative medicine permits the cultivation of tissues in the laboratory, their safe implantation, and regeneration. Stem cells possess a vast capacity to repair themselves and have numerous regenerative medicine applications. The development of biomaterials is another advance in regenerative medicine. Surface nanopatterning alters some biological reactions of host tissues, whereas nanotechnology supplies nanomaterials and scaffolds for TE (Pal et al., 2011).

Nanotechnology has increased to the top of the imaging business during the last 10 years. The area of orthopaedic surgery, which depends substantially on imaging technology, stands to benefit greatly from advances in the area. The semiconductor particles are known as quantum dots with a diameter of 2–10 nm that produce photons specific to the site imaging abilities. Quantum dots are valuable because they release particles when stimulated. The photon wavelength produced upon activation is exclusively regulated by the size of the dot, which can be accurately modified (Brenner and Ling, 2012). R-affixed self-illuminating quantum nanomaterials. Reniformis luciferase (RLuc) (So et al., 2006) is of special importance in orthopaedic surgery (Xing et al., 2008; Smith et al., 2009).

Certain applications need a higher spatial resolution to appropriately recognize abnormal properties, although most orthopaedic imaging applications concentrate on macroscale distinction. Osteoporosis, the most predominant degenerative disease in the West, is on top of the list because it needs in-depth imaging to determine the density and morphology of afflicted bone. At present, standard computed tomography (CT) has a resolving power of slightly around 1 mm, which is too big to view microscopic bone characteristics for instance osteocyte lacunae and canaliculi that link them. Quantitative imaging is made possible by a new technology that uses ptychographic CT to construct 3D density studies having a resolution of less than a micron. In contrast to standard lenses, ptychography is predicated on refractive microscopy. It makes use of sensors with fast speeds to gather micro-diffraction patterns created when electromagnetic (EM) radiation (X-ray in this example) contacts the sample (Dierolf et al., 2010).

Magnetic resonance imaging (MRI) is another modality that will be enhanced by nanotechnology. Sykova and others were able to track cellular movement using images of T2-weighted MRI (Sykova and Jendelova, 2007) by labeling embryonic stem cells (ESCs) and bone marrow MSCs with superparamagnetic iron oxide (SPIO) nanoparticles. They were able to effectively trace cellular movement in models with cortical and spinal lesions using this visualization system. The ability to employ tracers to pinpoint the exact position of brain lesions implies that future site-specific therapies may be possible.

Implantable biomaterials include magnesium alloys, stainless steel alloys, Ti alloys, cobalt-chrome alloys, alumina, HA, zirconia, carbon fiber/polyetherether-ketone, poly(lactic acid) (PLA), polymethylmethacrylate (PMMA), and carbon fiber/ultra-high molecular weight polyethylene are common materials that can be used to replace bone structurally (Pishbin et al., 2013; Liu et al., 2014; Pompa et al., 2015). Nanostructured materials have become innovative orthopedic implants with better potential for osseointegration as a result of recent advancements in nanotechnology while in contrast to conventional materials, they possess cell-favorable surface characteristics that effectively promote the formation of new bone (Zhang and Webster, 2009). For example, metallic implanted devices that have been nanostructured have improved mechanical and biocompatibility characteristics (Mishnaevsky et al., 2014). Currently, powder metallurgy (P/M) (Mishnaevsky et al., 2014) and severe plastic deformation (SPD) (Serra et al., 2013) methods may be used to economically produce bulk nanocrystalline (NC; <100 nm) and ultrafine-grained (UFG; ∼100–500 nm) metals, containing Ti and related alloys. In this case, strong plastic strains with complicated stress states are applied to bulk metal or powder materials, which causes the coarse grains to break down into the nanoscale range. While having a greater strength (>1,000 MPa) than traditional implants, SPD’s nanostructured titanium implants are bioinert and free of any possible harmful or allergic reactions from alloying elements like Al and V (Serra et al., 2013). A recent research by Gain et al. (Gain et al., 2015), has demonstrated that UFG/NC P/M Ti grafts exhibit superior strength and ductility compared to standard Ti–6Al–4V alloys and SPD-processed Ti components. UFG Ti (170–200 nm) was produced by Estrin et al. (Estrin et al., 2011), using equal channel angular pressing (ECAP) and contrasted the way that a coarse-grained (CG) Ti specimen (4.5 μm) adhered to the surface of hMSCs. It was revealed that there were improvements in the attachment and dissemination of hMSCs within the first 24 h of culture. TiN-coated UFG Ti (∼130 nm) was created by Wang et al. (Wang et al., 2013), using a high-pressure torsion process. The produced material’s strong strength, acceptable ductility, good fatigue life, outstanding abrasion resistance, and harmless ion release show its significant potential as an implant. Park et al. (Park et al., 2009), examined the in vitro biocompatibility of UFG Ti generated by ECAP utilizing MC3T3-E1 cells in comparison to Ti–6Al–4V alloy and commercially pure (CP) Ti. The samples have micro-rough surfaces created by grit-blasting them with HA particles. Alkaline phosphatase (ALP) activity, adhesion, osteocalcin, and osteopontin mRNA levels in growing cells, cell spreading, vitality, and mineralization nodule formation were among the improved biological responses shown by the UFG material. Element selenium is another substance used in orthopedics that may have anticancer properties. Selenium, as opposed to titanium, is a necessary trace element in human body. Mammalian selenoproteins, which are involved in thyroid hormone metabolism, antioxidant defense mechanisms, and redox regulation of cell processes, make selenium an essential element (Perla and Webster, 2005). The development of several malignant cell lines has been demonstrated to be inhibited by selenium in vitro study (Tran et al., 2010). Selenium has been shown by Perla and Webster (Perla and Webster, 2005) to positively impact osteoblast development. In order to develop roughness on selenium compacts with a nanostructure for chemotherapeutic orthopedic uses, Tran and Webster (Tran and Webster, 2008) shown that a higher level of nanometer-scale selenium roughness enhanced the adherence of healthy bone cells. But because selenium is a metalloid and lacks sufficient mechanical strength, this method of adding selenium may leave the implant with weak or inappropriate mechanical qualities (Figure 7) (Tran and Webster, 2008). Furthermore, stability and control over selenium’s release would be highly desired qualities given that it is poisonous in excessive amounts (Tran et al., 2010). Tran et al. (Tran et al., 2010), have produced a nano selenium-coated Ti to enhance orthopedic applications as an alternate method of employing selenium as an antitumor orthopedic material. Selenium nanoclusters’ potential as a covering for Ti orthopedic materials that can prevent cancer and support the normal functioning of bone cells has been shown. The hardest materials to work with in orthopedic applications include bioceramics, although their innate brittleness prohibited their use in particular applications. Improved fracture toughness and the potential to support biofunctionality are two benefits that nanophased ceramics may provide (Catledge et al., 2002). The nanostructuring of several bioceramics, such as alumina, titania, calcium phosphates, zirconia, bioactive glass (BG), and HA, is one of the most recent developments (Simchi et al., 2011). Research has indicated that nanostructuring results in increased mechanical strength together with enhanced ductility and toughness because the smaller grains prevent dislocation slip and blunt cracks (Ovid’ko and Sheinerman, 2011). Furthermore, when the sintering activity increases, manufacturing nanoceramics at reduced temperatures becomes possible (Simchi et al., 2011). In the meanwhile, it might be difficult to limit grain expansion during high-temperature processing. Additionally, nanophased bioceramics work better with cells in vivo and in vitro. When it comes to rabbit MSC cell survival and propagation in vitro, Zhou et al. (Zhou et al., 2015), have found that NC HA offers a superior substrate than CG HA. Enhanced apoptosis of bone-like HA nanocrystals modified with alendronate has been seen in osteoclast-like cells demonstrated in vitro by Bosco et al. (Bosco et al., 2015). In a critical-sized malfunction rabbit ulnar model, effective crack bridging is achieved using nanostructured BG scaffolds directing bone growth (Hafezi et al., 2012). The usage of nanotextured surface and nanoengineered grafts will support in fixing the problem by increasing activity of osteoblastic cells. The increased surface area of nanoengineered grafts allowed greater interaction between the host bone and the graft surface, opening the way to dependable and anticipated osteointegration, thereby lengthening the lifespan of implants. (Guarino et al., 2019; Abaszadeh et al., 2023).

Further, options for bone and potential uses for cartilage tissue engineering include artificial and natural polymers. Biocompatible and physiologically active natural polymers that support cell adhesion and growth include fibrin, collagen, chitosan (CS), HA, and alginate (Agarwal and García, 2015). These natural substances are superior to synthetic ones in sharing similarities with bodily materials and might be employed as scaffolding for the surface of implants (Park et al., 2007; Gallo et al., 2014). Recent developments in the creation of CS-based scaffolds with improved bone redevelopment potential were highlighted by Zhang and Levengood (Streicher et al., 2007). Mandal et al. (Mandal et al., 2012) created composite matrices bonded with silk fibers for use in bone engineering that have a high compressive strength (∼13 MPa in a hydrated condition). To facilitate bone regeneration nanomedicine, Schiavi et al. (Schiavi et al., 2015) created novel collagen nanofiber implants that are personalized with growth factor BMP-7 nanoreservoirs and fortified with MSCs from humans. Additionally, a wide variety of polymer nanofibers have been researched for use in replacing bone tissue (Streicher et al., 2007). Using methods including phase disparity, particle leaching, electrospinning, 3D printing and chemical etching, these nanofibrous or nanoporous polymer matrices may be created (Zhang and Webster, 2009). To investigate the survival, propagation, and differentiation of hMSCs along with their derivatives that are chondrogenic and osteogenic, Xin et al. (Xin et al., 2007) synthesized electrospun PLGA nanofibrous scaffolds. Findings showed that during a 2-week incubation period in PLGA nanofibers, hMSCs consistently differentiated into osteogenic and chondrogenic cells. Improved chondrocyte activities on nanostructured 3D PLGA scaffolds were reported by Park et al., (Park et al., 2005).

Generally speaking, nanopolymers and nanoceramics are employed primarily as coating component material in orthopedic or can be mixed with other biomaterials to create nanocomposites appropriate for use in implants. Since bone is a real nanocomposite, as was previously established, nanocomposites are more advantageous compared to alternative nanostructured materials. Commonly used nanocomposites for the regeneration of bone tissue include carbonaceous nanophases in ceramic or polymer matrix, ceramic nanophases in ceramic matrix, and ceramic nanophases in polymer matrix (Yang et al., 2011; Garmendia et al., 2013). When porous HA/ZrO₂ nanocomposites were created using the P/M approach, as demonstrated by Gain et al. (Gain et al., 2015). The reinforcing action of ZrO₂ nanoparticles (NPs) allowed the nanocomposites to display superior compressive strength and elastic modulus compared to porous monolithic HA. A growing number of researchers are interested in using ceramic-polymer nanocomposites as materials for bone tissue regeneration because of the extraordinary fusion of osteoconductivity and bioactivity in ceramics and flexibility and form controllability in polymers (Sahoo et al., 2013). Hickey et al. (Hickey et al., 2015), have created PLLA-based nanocomposites reinforced with MgO NPs and HA very recently. According to their findings, MgO NPs considerably improve osteoblast adhesion and propagation on HA–PLLA nanocomposites while preserving mechanical characteristics appropriate for applications involving cancellous bone. For the medical management of cancellous bone deformities or orthopedic applications with limited load bearing, Sadat-Shojai et al. (Sadat-Shojai et al., 2015) created 3D HA/gelatin hydrogel nanocomposites with increased rigidity. The incorporation of MC3T3-E1 cells into the nanocomposites demonstrated that the bone cells were compatible with the whole composite manufacturing process. Carbon nanoparticles are new, substitute reinforcing materials. The mechanical characteristics of orthopedic materials can be effectively enhanced by the addition of carbon nanostructures, such as graphene, carbon nanofibers, carbon nanotubes, nanodiamond (ND), and so on, because of their very high mechanical strength compared to most other materials (Yang et al., 2011). By employing a hydrothermal method, Baradaran et al. (Baradaran et al., 2014), created composites of graphene oxide (rGO) reinforced graphene (HA) nanotubes. They demonstrated that increasing the rGO concentration enhanced the sintered specimens’ elastic modulus and fracture toughness. Additionally, there were reports of increased osteoblast adhesion and propagation. Wu et al. (Wu et al., 2013), examined the biomimetic development behavior of HA on carboxylic group-customized CNFs and assessed the composites’ fracture strength and structure. The enhanced mechanical strength and ability for HA to form an interfacial link with host tissues were achieved as a result of the strong interfacial interaction between HA and CNFs. Another research investigation (Liao et al., 2013) created biocomposites for bone replacements by combining HA nanorods and multiwalled carbon nanotubes (MWCNTs) with polypropylene. The 3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay and mechanical testing indicate that the mechanical properties—like impact toughness, tensile strength, and stiffness—were enhanced without significantly affecting biocompatibility.

Nanotechnology has made a significant impact in medicine, and substantial financing is being dedicated to nanomedicine investigation. Most effective in vitro and laboratory-based studies have yet to be converted in clinical settings, despite the reality that the theoretical benefits of nanotechnology are exceptional. There are concerns in relation to the toxicity of NPs produced as abrasion detritus. At the nanoscale, metals exhibit distinct behaviors and material qualities than at the microscale. The small metal ion particles have made havoc with metal-on-metal (MOM) hip substitutions. Therefore, traditional grafts cured by nanotechnology for exact characteristics are preferable over nanoparticle implants. This prevents nanoparticles from becoming dispersed and causing tissue toxicity. Given these reservations, it has been suggested that regulation is required. Industries are still unwilling to make nanostructured grafts and prostheses due to unproven healing advantages, probable toxicity risks, and prohibitively high prices. In conclusion, we consider that nanotechnology progressions will continue to influence medicine’s future, specifically orthopedics. To achieve the prospective clinical benefits, additional investigation is required, which requires regulated regulation in the absence of impeding research avenues.